Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hence the need to raise capital over the next two years.
What a cluster****.
Please explain why abdicating his responsiblities as CEO is a positive.
On a positive note,,,,since he has been CEO he hasn't been in he public eye very much...
What's the counterparty expect, Flub?
Easy pickings.
I'm probably wrong, but "insider buying" probably isn't a thing as far as insider trading is concerned. It might be, technically, but is buying stock a breach of a fiduciary duty? And is this ever adjudicated?
No.
wrong re: delisting. after 30 consecutive days under $1, the company is warned and they then have 180 days to get it above $1.
and even then they can ask for an extension which is usually granted.
They're not a phase 3 company.
At best, they're 2 for 4. And hemorrhaging cash.
you are a useless retard, fnds.
LOL!
What's your take besides the buyers of course are much much more intelligent than the sellers.
I can't believe the market has rewarded such fuckery (not that I mind).
As you know, HTFS (amongst the other learned here), there is no such evidence. Only...
Proof by assertion
Blue, what is your evidence for this belief? I have read studies which show there is virtually no hft in small cap low price low volume stocks. I can send the links if you want. Can you send your links to the evidence that adxs has been manipulated by algos, whatever that means to you? If you have no evidence, a rational person would question their beliefs.
Because CW has never had a deadline that he couldn't miss.
As easy as everyone makes it sound, why in Feb did CW say trials (in human, I can't see why the FDA would want this crap with such a miraculous drug) were starting in the first half and then months later move the trials to the second half of 18'?
Agreed.
that speaks to the company's credibility. as does the reverse split. as does the recent cash raise. as do the clinical holds. as does the ema rejection.
new guy's plate is full.
How is ADXS a "late-stage" biotechnology company?
people are irrational. even rsu holders.
cherry picking.
smart robots just don't understand.
Share price is down, month over month. Are there really less sellers?
didn't some folks have cdxs a year or two ago?
too early, i guess.
Why do you think there is a payment associated with this milestone?
Did he say anything about raising capital or funding the remaining programs?
Is this right? Yahoo charts indicates TPIV has reverse split four times - for a net 30,000 to 1.
Wow.
I wonder what the OS for pembro alone would be. Has this been studied?
Please, tell us about this milestone. If it's not a pretend thing, please share a link.
Regardless of how you label it, a $20m milestone would be very significant, and provide time and breathing room. To suggest otherwise is ridiculous.
uh, no.
already tested in samples from HUMAN PATIENTS!!
Good luck. There's some pretty strong downside resistance in the $12 area.
The net present value of ADXS warrants is less than zero due to transaction costs.
Avoid.
urban myth.
most institutions are prohibited from buying below $5
It's not in this company's nor this CEO's DNA not to dilute.
what do you mean by "new"?
why does it matter?
Amusing that you compare a nearly broke (again) company that has already reversed split it shares (once, so far) to AMZN, MSFT, etc.
I'm surprised you didn't include a Warrren Buffet lecture in your post.
Who's we? Employees? The executive suite?
Current common shareholders will be diluted into oblivion. Warrant holders just give up now.
Or they're milking it for as much cash as possible before the bankruptcy auction.
You're fooling yourself. The downside isn't limited, it's 100%.
it is not reasonable to expect that AMGN would abandon their fiduciary duties and pay that kind of crazy multiple for any company.
Especially for a company that can't accomplish anything.
It's not going to happen. Peanuts or not.
Thanks, jbog. I appreciate your posts. You're certainly right more than you're wrong.
ADXS clearly and demonstably has bad management.
It's not even arguable.
The market is saying the expected value of risk-adjusted, discounted cash flow is $1.72 per existing share.
Maybe ADXS is worth several billion dollars down the road but that matters little if the expected severe dilution happens during the intervening time.
$10, $20, $60? You're dreaming.